Global Bovine Mastitis Market to reach USD XX billion by 2027Global Bovine Mastitis Market is valued approximately at USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than 5.1% over the forecast period 2021-2027. Bovine mastitis is a health condition that affects dairy animals which causes inflammation of the mammary gland and udder tissue. The illness can harm the cattle's milk-secreting tissues, which is one of the main reasons why it's considered a significant problem. The growing global prevalence of bovine mastitis will have a direct influence on the overall market's growth in the future years. Furthermore, mastitis is a hazard to human health since it can cause zoonoses and food toxin infections. The market is being driven by increase in product launches for animal healthcare and rise in the incidence of disease. For instance, the launch of a new medicine to protect dairy cattle from immunological illnesses was announced by Boehringer Ingelheim International GmBH in October 2018. The company launched 'Lockout,' a treatment that will help dairy cattle avoid post-immunotherapy problems, boosting their health and performance. This will also enhance the final products from dairy farming. However, lack of awareness about disease may impede market growth over the forecast period of 2021-2027.

North America is found to hold a significant share of the bovine mastitis market due to the strong adoption of intra-mammary infusion products for the treatment and the presence of leading players in the region offering a wide range of products for the control of the infection. It is expected to show a similar trend over the forecast period, with no significant fluctuations. The presence of large-scale companies in North America will have an impact not only on the regional market growth but also on the global market growth.

Major market player included in this report are:
Advanced Animal Diagnostics
Zoetis Inc.
Boehringer Ingelheim International GmbH
West Way Health
ImmuCell Corporation
Merck & Co., Inc.
Nimrod Veterinary Products Ltd
Bayer AG
Norbrook
DeLaval


The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:
Clinical Mastitis
Sub-Clinical Mastitis
By Type:
Antibiotics
Surgery
Vaccines
Pain Killers
Others
By Route of Administration:
Intra-Mammary
Systemic
By therapy:
Lactating Period
Dry Period
By End user:
Hospitals and Clinics
Veterinary Centers
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027.

Target Audience of the Global Bovine Mastitis Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors